Tyra Biosciences, Inc. (TYRA)
NASDAQ·Healthcare·Biotechnology
$35.00
-5.02%
Mkt Cap $1.97B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 2, 2026 | — | — | — | -$0.54 | -$0.57 | -5.56% | — | — |
| Q4 2025 Nov 5, 2025 | — | — | — | -$0.50 | -$0.50 | +0.00% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.53 | -$0.47 | +11.32% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$0.49 | -$0.47 | +4.08% | — | — |
| Q1 2025 Mar 27, 2025 | — | — | — | -$0.48 | -$0.43 | +10.42% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.40 | -$0.41 | -2.50% | — | — |
| Q3 2024 Aug 7, 2024 | — | — | — | -$0.41 | -$0.32 | +21.95% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.46 | -$0.35 | +23.91% | — | — |
| Q1 2024 Mar 19, 2024 | — | $502.00K | — | -$0.48 | -$0.53 | -10.42% | — | — |
| Q4 2023 Nov 7, 2023 | — | — | — | -$0.35 | -$0.49 | -40.00% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.34 | -$0.31 | +8.82% | — | — |
| Q2 2023 May 4, 2023 | — | — | — | -$0.37 | -$0.28 | +24.32% | — | — |
| Q1 2023 Mar 22, 2023 | — | — | — | -$0.35 | -$0.31 | +11.43% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$0.41 | -$0.30 | +26.83% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$0.33 | -$0.36 | -9.09% | — | — |
| Q2 2022 May 5, 2022 | — | — | — | -$0.20 | -$0.36 | -80.00% | — | — |
| Q1 2022 Mar 3, 2022 | — | — | — | -$0.21 | -$0.24 | -14.29% | — | — |
| Q4 2021 Nov 3, 2021 | — | — | — | -$0.29 | -$0.72 | -148.28% | — | — |
| Q3 2021 Sep 15, 2021 | — | — | — | — | -$0.19 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.15 | — | — | — |